Macrophage-targeting immunotherapy enhances chemotherapy response in primary and metastatic triple-negative breast cancer models

被引:0
|
作者
Fernandez, Matthew Emilio
Alshehry, Yasir
Graham, Laura
Koblinski, Jennifer E.
Bear, Harry D.
Sweet, Doug H.
da Rocha, Sandro R.
机构
关键词
D O I
10.1158/1538-7445.AM2024-6521
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
6521
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Macrophage-targeting immunotherapy for triple negative breast cancer
    Fernandez, Matthew E.
    Fines, Cory B.
    Subul, Fatemah S.
    Alhudaithi, Sulaiman S.
    Bear, Harry D.
    Sweet, Douglas H.
    da Rocha, Sandro R.
    CANCER RESEARCH, 2023, 83 (07)
  • [2] Gefitinib enhances response to chemotherapy in triple-negative Breast Cancer (BrCa)
    Corkery, B.
    O'Donovan, N.
    Clynes, M.
    Crown, J.
    EJC SUPPLEMENTS, 2007, 5 (04): : 185 - 185
  • [3] Immunotherapy in Combination with Chemotherapy for Triple-negative Breast Cancer
    Elizabeth, Melendez Solano
    Cristina, Stevens Barron Jazmin
    Christian, Chapa Gonzalez
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2024, 24 (04) : 431 - 439
  • [4] Novel immunotherapy approach for metastatic triple-negative breast cancer
    Griffin, Paul
    Jain, Riya
    Le, Sean
    Rajapakse, Kyle
    Miller, Wilson
    Andarawewa, Kumari
    CANCER IMMUNOLOGY RESEARCH, 2024, 12 (10)
  • [5] Combining Chemotherapy and Immunotherapy for the Treatment of Triple-Negative Breast Cancer
    McArthur, Heather
    ONCOLOGY-NEW YORK, 2019, 33 (04): : 137 - 140
  • [6] Immunotherapy in Triple-Negative Breast Cancer
    Emens, Leisha A.
    CANCER JOURNAL, 2021, 27 (01): : 59 - 66
  • [7] Immunotherapy in triple-negative breast cancer
    Katz, Heather
    Alsharedi, Mohamed
    MEDICAL ONCOLOGY, 2018, 35 (01)
  • [8] Immunotherapy for Triple-Negative Breast Cancer
    Cao, Yifeng
    Chen, Chuyang
    Tao, Yi
    Lin, Weifeng
    Wang, Ping
    PHARMACEUTICS, 2021, 13 (12)
  • [9] Immunotherapy in triple-negative breast cancer
    Heather Katz
    Mohamed Alsharedi
    Medical Oncology, 2018, 35
  • [10] 'IMpassionate conflicts' in immunotherapy trials for metastatic triple-negative breast cancer
    Voorwerk, L.
    Kok, M.
    ANNALS OF ONCOLOGY, 2021, 32 (08) : 947 - 949